JAMRX
Price
$97.71
Change
-$1.17 (-1.18%)
Updated
Nov 18 closing price
Net Assets
29.4B
RGACX
Price
$82.69
Change
-$0.58 (-0.70%)
Updated
Nov 18 closing price
Net Assets
329.73B
Interact to see
Advertisement

JAMRX vs RGACX

Header iconJAMRX vs RGACX Comparison
Open Charts JAMRX vs RGACXBanner chart's image
Janus Henderson Research T
Price$97.71
Change-$1.17 (-1.18%)
VolumeN/A
Net Assets29.4B
American Funds Growth Fund of Amer R3
Price$82.69
Change-$0.58 (-0.70%)
VolumeN/A
Net Assets329.73B
JAMRX vs RGACX Comparison Chart in %
View a ticker or compare two or three
VS
JAMRX vs. RGACX commentary
Nov 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JAMRX is a Hold and RGACX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 330B vs. JAMRX (29.4B). RGACX pays higher dividends than JAMRX: RGACX (0.07) vs JAMRX (0.00). JAMRX was incepted earlier than RGACX: JAMRX (33 years) vs RGACX (24 years). RGACX (0.94) is less costly to investors than JAMRX (0.79). JAMRX is a more actively managed with annual turnover of: 27.00 vs. RGACX (25.00). RGACX has a lower initial minimum investment than JAMRX: RGACX (250) vs JAMRX (2500). JAMRX annual gain was more profitable for investors over the last year : 12.87 vs. RGACX (6.60). JAMRX return over 5 years is better than : 55.45 vs. RGACX (30.90).
JAMRXRGACXJAMRX / RGACX
Total Expense Ratio0.790.9484%
Annual Report Gross Expense Ratio0.790.9484%
Fund Existence33 years24 years-
Gain YTD15.42814.863104%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets29.4B330B9%
Annual Yield % from dividends0.000.07-
Returns for 1 year12.876.60195%
Returns for 3 years99.2460.28165%
Returns for 5 years55.4530.90179%
Returns for 10 years112.9284.84133%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BBC33.750.87
+2.65%
Virtus LifeSci Biotech Clinical Trls ETF
HQL17.250.09
+0.52%
abrdn Life Sciences Investors
JMUB50.720.08
+0.15%
JPMorgan Municipal ETF
NSEP28.55-0.10
-0.35%
Innovator Growth-100 Pwr Buffr ETF - Sep
PFO9.51-0.05
-0.52%
Flaherty & Crumrine Preferred and Income Opportunity Fund